The efficacy benefits of biphasic insulin aspart formulation (BIAsp 30) in patients with diabetes mellitus have been reported in several studies. BIAsp 30 has been shown to be more effective in ...

A trial conducted in eight countries, including India has shown that using biphasic BIAsp 30 insulin can lead to significant clinical improvements and greater patient satisfaction. A trial ...

reported interim results of a 3 year, open-label, randomized, controlled, multicenter trial comparing the efficacy and safety of adding biphasic, prandial or basal insulin to oral therapy for ...

In patients with type 2 diabetes (n = 61), the frequency of severe episodes was similar for BIAsp 30, BHI 30 and biphasic insulin lispro 25. Overall numbers of episodes were 23 with BIAsp 30 ...